- Home
- SNAL vs BEAT Comparison
SNAL vs BEAT Comparison
Compare SNAL & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNAL
- BEAT
- Stock Information
- Founded
- SNAL 2000
- BEAT 2015
- Country
- SNAL United States
- BEAT United States
- Employees
- SNAL N/A
- BEAT N/A
- Industry
- SNAL Computer Software: Prepackaged Software
- BEAT Retail: Computer Software & Peripheral Equipment
- Sector
- SNAL Technology
- BEAT Technology
- Exchange
- SNAL Nasdaq
- BEAT Nasdaq
- Market Cap
- SNAL 59.1M
- BEAT 65.4M
- IPO Year
- SNAL 2022
- BEAT 2021
- Fundamental
- Price
- SNAL $0.83
- BEAT $2.00
- Analyst Decision
- SNAL
- BEAT Buy
- Analyst Count
- SNAL 0
- BEAT 1
- Target Price
- SNAL N/A
- BEAT $8.00
- AVG Volume (30 Days)
- SNAL 55.6K
- BEAT 57.4K
- Earning Date
- SNAL 03-26-2025
- BEAT 03-13-2025
- Dividend Yield
- SNAL N/A
- BEAT N/A
- EPS Growth
- SNAL N/A
- BEAT N/A
- EPS
- SNAL 0.05
- BEAT N/A
- Revenue
- SNAL $84,467,047.00
- BEAT N/A
- Revenue This Year
- SNAL $26.80
- BEAT N/A
- Revenue Next Year
- SNAL N/A
- BEAT N/A
- P/E Ratio
- SNAL $17.64
- BEAT N/A
- Revenue Growth
- SNAL 38.69
- BEAT N/A
- 52 Week Low
- SNAL $0.52
- BEAT $1.70
- 52 Week High
- SNAL $3.42
- BEAT $3.48
- Technical
- Relative Strength Index (RSI)
- SNAL 27.38
- BEAT 46.64
- Support Level
- SNAL $1.57
- BEAT $1.85
- Resistance Level
- SNAL $1.70
- BEAT $2.03
- Average True Range (ATR)
- SNAL 0.17
- BEAT 0.11
- MACD
- SNAL -0.06
- BEAT 0.00
- Stochastic Oscillator
- SNAL 0.00
- BEAT 51.35
About SNAL Snail Inc.
Snail Inc is a global independent developer and publisher of interactive digital entertainment for consumers around the world, with a premier portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.